https://www.selleckchem.com/products/cy-09.html
ikely to receive chemotherapy as cumulative social risk increased. Cumulative social risk was associated with reduced receipt of chemotherapy. These associations were mitigated by social support. Assessing cumulative social risk may identify patients with colorectal cancer who are at higher risk for omitting chemotherapy who can be targeted for support programs to address social disadvantage and increase social support. Cumulative social risk was associated with reduced receipt of chemotherapy. These associations were mitigated by social
Like
Comment
Share
